amino-terminal sequence, which in turn serves as a tethered ligand, binding the body of the receptor to trigger transmembrane signaling (9, 26) . Molecular cloning has identified four PARs: PAR-1 and PAR-3, which are both preferentially activated by thrombin (38) ; PAR-2, which is selectively activated by trypsin (2, 29, 30) ; and PAR-4, which is activated by both thrombin and trypsin (38) . In addition to endogenous proteases, PARs can be selectively activated by short agonistic peptides (APs) such as SLIGRL (SL)-NH 2 , a synthetic peptide that corresponds to the rat/mouse tethered ligand exposed after PAR-2 cleavage (1-4, 6, 8, 19-21) .
Although PAR-2 is highly expressed in the gastrointestinal tract in epithelial cell, neuronal, and muscular elements (7, 11, 17, 30) , the effect it exerts on gastric secretory functions is still poorly defined. In a recent study, however, Kawao et al. (20) reported that repeated injections of SL-NH 2 to pylorus-ligated rats facilitates pepsinogen release in vivo, suggesting that PAR-2 acts as an endogenous mediator in pepsinogen secretion.
Pepsin is the main protein secreted by gastric epithelial cells and is released within the gastric lumen in response to a variety of neurohumoral stimuli by pepsinogen-secreting (chief) cells (10) . This cell subtype represents Ϸ40% of gastric epithelial cells and possesses G protein-coupled, seven-transmembrane-domain receptors that modulate pepsinogen release in response to peptide and nonpeptide agonists (10, 12-16, 31, 32, 34, 35) . Binding of gastric chief cell receptors with specific agonists results in activation of at least two major intracellular pathways. Secretin, vasointestinal peptide (VIP), and PGE 2 cause pepsinogen release by increasing intracellular concentrations of cAMP and PKA (10, 12-16, 32, 33, 35, 36) . In contrast, gastrin, CCK, and muscarinic receptor agonists induce intracellular Ca 2ϩ mobilization and PKC activation (10, 12-16, 32, 33, 35, 36) . Although these pathways are functionally separated, a certain degree of interaction at postreceptor levels exists as demonstrated by the fact that simultaneous activation of PKA and PKC with specific agonist leads to a potentiation of pepsinogen release (16, 32) . Furthermore, exposure of isolated chief cells to agonists might also result in pepsinogen secretion desensitization, a process that involves both receptor and postreceptor events, suggesting that interaction with other agonists might affect the ability of cells to respond to PAR-2 AP (12) (13) (14) (15) (16) 32) . Because in several cell systems PAR-2 activation associates with Ca 2ϩ mobilization and PKC activation (9, 27) , we have designed a study to examine whether SL-NH 2 stimulates pepsinogen release from gastric-isolated chief cells and to define intracellular messengers involved in this effect.
MATERIALS AND METHODS

Materials.
Male Hartley guinea pigs (200-400 g) were obtained from Charles River (Monza, Italy). DMEM was from GIBCO. HEPES, BSA fraction V, atropine, soybean trypsin inhibitor, collagenase (type I), carbamylcholine (carbachol), atropine, capsaicin, EGTA, fura 2-AM, BAPTA, and a lactate dehydrogenase (LDH) kit were from Sigma (St Louis, MO). Essential amino acid mixture and 1% essential vitamin mixture were from GIBCO (Milan, Italy); Percoll was from Pharmacia (Uppsala, Sweden); secretin and CCK-8 were from Peninsula Laboratories (St. Helens, Merceyside, UK). Nacetyl-L-tryptophan 3,5-bis(trifluoromethyl)benzyl ester (L-732,138), Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH 2, (substance P), and Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2 (MEN-10,376) were from Biomol Research Laboratories (Plymouth Meeting, PA). 2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD-98,059), a specific MEK inhibitor (1), was from Calbiochem (San Diego, CA). SLIGRL-NH 2 and LSIGRL-NH2 (LS) were a kindly donated by Vincenzo Santagada and Giuseppe Caliendo (Department of Medicinal Chemistry, University of Naples, Italy).
Chief cell preparation. Chief cells from the guinea pig stomach were prepared as previously described (12) (13) (14) (15) (16) by collagenase digestion and Ca 2ϩ chelation by omitting trypsin digestion (33) . This method yields a cell population that is ϳ90% chief cells, 5% parietal cells, and 5% other cells. The purity of each chief cell preparation was verified daily by light microscopy, and the number of cells were counted. Chief cells were suspended in a standard incubation solution containing (in mM) 24.5 HEPES, 120 NaCl, 7.2 KCl, 1.5 Ca 2Cl, 0.8 MgCl2, 2.6 KH2PO4, 14 glucose, 6 Na-pyruvate, 6 glutamate, 7 fumarate, 2 glutamine, and 0.1% (wt/vol) albumin, 1% (vol/vol) essential amino acid mixture and 1% (vol/vol) essential vitamin mixture. The pH was 7.4, and all incubations were performed at 37°C with 100% O 2.
In some experiments, chief cells were prepared from guinea pigs pretreated with capsaicin. Under halothane anesthesia, animals received three doses of capsaicin (25, 50 , and 50 mg/kg sc) dissolved in vehicle (10% ethanol, 10% Tween 80, sterile physiological saline) over 32 h (at 0, 6, and 32 h, respectively; 125 mg/kg total dose) or an equivalent volume of vehicle. This treatment has previously been demonstrated to deplete substance P-like and calcitonin generelated peptide (CGRP)-like immunoreactivity from extrinsic afferent neurons in the gastrointestinal tract (18) . The efficacy of the capsaicin treatment was verified by the eyewiping test, as described previously (17, 18) . All control animals received administration of vehicle. Chief cells were prepared from capsaicin-treated and control guinea pigs 7 days after the last injection of capsaicin or vehicle.
RT-PCR.
After the rats were killed, stomachs were removed and immediately snap-frozen in liquid nitrogen and stored at Ϫ80°C until used. Total RNA was isolated by using TRIzol reagent (Life Technologies, Milan, Italy) as previously described (17) . PCR was performed by using specific primers. For ␤-actin (543 bp), the sense primer was 5Ј-TGT GAT GGT GGG AAT GGG TCA G-3Ј and the antisense primer was 5Ј-TTT GAT GTC ACG CAC GAT TTC C-3Ј (Stratagene, La Jolla CA). Oligonucleotide primers for guinea pig PARs were forward, 5Ј-CAT GTT CAG CTA CTT CCT CTC CTT-3Ј and reverse, 5Ј-GGT TTT AAC ACT GGT GGA GCT TGA-3Ј and were chosen to amplify a 472-bp fragment. The cDNA was amplified with a "hot start" reaction in 20 l of reaction containing 5 l cDNA product, 2 l PCR buffer (200 mM Tris ⅐ HCl, pH ϭ 8; 4,500 mM KCl), 200 M dNTPs, 1 M of sense and antisense primers, 1.5 mM MgCl 2, 1 U platinum Taq polimerase (Life Technologies), and water in a Hybaid PCR Sprint thermocycler (Celbio, Milan, Italy). PCR was carried out as previously described (17) . The size of PCR products was assessed by comparison with a 1-g 100-bp DNA ladder (Life Technologies). The gel was photographed under ultraviolet transillumination with a Kodak Digital Science ID Image Analysis Software (Kodak, Milan, Italy), and images were digitalized. Each assay was carried out in triplicate. The ␤-actin was used as a control for both reverse transcription and the PCR reaction itself.
Immunohistochemistry. Cytospins of gastric chief cells were air-dried overnight and fixed in acetone at 4°C for 5 min, washed in PBS, dipped in methyl alcohol with 0.3% hydrogen peroxide for 10 min for blocking of endogenous peroxidase activity, washed three times in PBS, and incubated in 0.1% albumin for 30 min. Immunostaining of PAR-2 was performed by using a rabbit polyclonal antibody (B5) that specifically recognizes PAR-2, targeted to a peptide corresponding to the cleavage/activation site of rat PAR-2 ( 30 GPNSKGR2SLIGRL-DT 46 P-YGGC) (19, 25) . Sections were first incubated in 1% normal goat serum for 30 min and then in the B5 antibody at a dilution of 1:1,000 for 16 h at 4°C (19) . Immunoreactivity was visualized with the use of biotinylated goat anti-rabbit IgG followed with streptavadin-conjugated peroxidase (Sigma, St. Louis, MO) and color generation with diaminobenzidine for 30 min. Smears were counterstained with hematoxylin and mounted in ACQUOVI-TREX (Carlo Erba, Milan, Italy), and images were recorded by digital photomicrography. Controls were obtained by incubating smears with B5 antibody preadsorbed with the synthetic peptides (19) .
Effect of SL-NH2 and LS-NH2 on pepsinogen secretion. Chief cells (300,000/ml) were suspended in the standard incubation solution for 30 min alone or with concentrations of SL-NH2 or trypsin ranging from 1 pM to 100 nM. In some experiments, chief cells exposed to SL-NH2 were coincubated with maximally effective concentrations of the following agents: 30 nM secretin, 1 M VIP, 1 M PGE2, 30 M carbachol, and 3 nM CCK; pepsinogen released in cell supernatants was measured. To investigate whether pepsinogen secretion induced by SL-NH2, could be desensitized by another specific agonist, cells were pretreated with maximally effective concentrations of secretin, VIP, PGE2, carbachol, and CCK for 30 min (12-16, 31, 32, 34, 35) , and then, after extensive wash, cells were stimulated with 1 nM SL-NH2 and pepsinogen release in cell supernatants was measured. Pepsinogen released into the supernatant (250 l) was assayed by using acid-denatured hemoglobin as substrate, as described previously (12) (13) (14) (15) (16) Grynkiewicz et al. (19) . The fura 2-AM/Ca 2ϩ signal was calibrated at the end of each recording by adding digitonin followed by EGTA as described (13, 14) .
To investigate whether SL-NH 2 increased Ca 2ϩ influx, we used Mn 2ϩ as a Ca 2ϩ surrogate (14) . Fura 2-loaded cells were resuspendend in a Ca 2ϩ -free buffer and stimulated with 10 nM SL-NH2 (14) . Fluorescence was excited at 360 nm, i.e., the isosbestic wavelength at which Ca 2ϩ does not affect fura 2 fluorescence and changes in fluorescence intensity are only caused by Mn 2ϩ quenching. Emission was recorded at 505 nm. Maximal Mn 2ϩ quenching was calibrated in each preparation at the end of recording with digitonin (14) .
Western blot analysis of ERK. Isolated chief cells were pelleted and lysed in ice in (in mM): 50 Tris ⅐ HCl (pH 8.0), 150 NaCl, 1 EGTA (pH 8.0), 100 NaF, 1% MgCL 2, 1 Na3VO4, 1 PMSF, and 10% glycerol, 1% vol/vol Triton X-100, 10 g/ml leupeptin, and 5 g/ml aprotinin. Insoluble materials were removed by centrifugation at 12,000 g at 4°C for 10 min, and protein concentration was determined by protein assay reagent (Bio-Rad Laboratories, Hercules, CA). For Western blot analysis, 50 g of total lysates were electrophoresed on a 11% SDS-PAGE, blotted onto nitrocellulose membrane, and incubated with an anti-phospho-ERK, an antibody that specifically recognizes the active, phosphorylated form of ERK and that reacts with both p42 and p44 isoforms (Promega, Madison, WI) (14) . ERK kinase activation in response to SL-NH 2 is demonstrated by the appearance of protein bands at 42 and 44 kDa.
ERK activity. ERK activity was assessed by using the p42/p44 MAP kinase assay kit (Cell Signaling Tecnologies, Beverly, MA) according to the manufacturer's indications. In this method, a monoclonal antibody against p42/p44 ERK (Thr 202 and Tyr 204 ) is used to selectively immunoprecipitate phosphorylated ERK from cell lysates. The resulting immunoprecipitate is then incubated with an Elk-1 fusion protein in the presence of ATP, allowing active ERK to phosphorylate Elk-1. Immunoprecipitates were then resolved on 10% SDS-PAGE, blotted onto nitrocellulose membrane, and incubated with a phospho-Elk-1 antibody. Membranes were then incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibody. Band intensity was quantified as described previously (14) and expressed as fold of increase over basal values. To investigate whether ERK activation was required for pepsinogen release induced by PAR-2 AP, cells were incubated with 1-50 M PD-98,059, a specific MEK inhibitor (1), and pepsinogen release induced by SL-NH 2 was measured.
Statistical analysis. Data reported are means Ϯ SE of the number of experiments indicated. The statistical analysis was carried out by using a GraphPad Prism 3 (GraphPad Software, San Diego, CA). ANOVA and Student's t-test for paired data were employed when appropriate.
RESULTS
Chief cells express PAR-2.
At the immunohistochemical analysis, PAR-2-like immunoreactivities were found in the plasma membrane and cytosol of gastric chief cells (Fig. 1A) . PAR-2-like immunoreactivities were also found in gastric mucous cells but not in parietal cells. The PAR-2 immunostaining was abolished by preabsorption of the B5 antibody with 20 g/ml of antigenic peptide (Fig. 1B) . The RT-PCR analysis (Fig. 1C) demonstrates characteristic size transcript for PAR-2 (472 bp) in this cell preparation. Exposure to SL-NH 2 and trypsin has no effect on PAR-2 mRNA expression (data not shown). and maximal at 1 nM. Trypsin also stimulates pepsinogen secretion (Fig. 2B) . At the concentration of 1 nM, trypsin caused a 10-fold increase of pepsinogen release. The kinetic of pepsinogen secretion induced by SL-NH 2 and trypsin was biphasic (Fig. 2C ). Approximately 80% of total pepsinogen secretion induced by 1 nM SL-NH 2 was observed in the first 15 min of incubation, resulting in a rate of pepsinogen release of 0.76 Ϯ 0.05% per min. Pepsinogen secretion declined thereafter (15-to 60-minute interval) to 0.16 Ϯ 0.02% per minute. In contrast to SL-NH 2 , the scramble peptide LS-NH 2 did not stimulate pepsinogen release. Changes in pepsinogen release were not due to alteration of cell membrane permeability. Indeed, LDH activity in cell supernatants was 2.1 Ϯ 0.5, 2.4 Ϯ 0.5, 2.2 Ϯ 0.4, and 3.2 Ϯ 0.5% of total in control cells and in cells incubated with 1 nM SL-NH 2 , LS-NH 2 , or trypsin, respectively (n ϭ 6, not significant).
SL-NH 2 causes Ca 2ϩ mobilization. [Ca 2ϩ
] i increased from 184.4 Ϯ 45.3 to 543.7 Ϯ 55.6 and 689.4 Ϯ 64.6 nM after exposure to 10 nM SL-NH 2 and trypsin (Fig. 3A) . Ca 2ϩ mobilization induced by SL-NH 2 was time and concentration dependent with an ED 50 of Ϸ0.6 nM (Fig. 3, A and B) . Removal of extracellular Ca 2ϩ attenuated but did not abolish Ca 2ϩ signals induced by SL-NH 2 , indicating that PAR-2 activation in chief cells mobilizes both intra-and extracellular sources of Ca 2ϩ . Consistent with this view, exposure to SL-NH 2 increased the quenching rate of the fura 2 signal in the presence of Mn 2ϩ , indicating a net Ca 2ϩ influx during PAR-2 activation (Fig. 3C) . To investigate whether pepsinogen release induced by SL-NH2 was Ca 2ϩ de- pendent, chief cells were incubated with 1 mM BAPTA, an agent that binds intracellular Ca 2ϩ , in a Ca 2ϩ -free medium (Fig. 4, A and B) . Pepsinogen secretion of 2.1 Ϯ 0.3 rose to 18.5 Ϯ 1.9% in chief cells exposed to 1 nM SL-NH 2 (P Ͻ 0.05, n ϭ 4 experiments) but dropped to 8.5 Ϯ 0.8 in cells incubated in a Ca 2ϩ -free medium and to 5.2 Ϯ 0.5% in cells preincubated in a Ca 2ϩ -free medium in the presence of 1 mM BAPTA, (Fig. 4 , A and B; P Ͻ 0.01, n ϭ 6). In this setting, exposure to 1 nM SL-NH 2 failed to stimulate Ca 2ϩ mobilization (P Ͻ 0.01, n ϭ 6), indicating that pepsinogen release induced by PAR-2 activation is Ca 2ϩ dependent and requires both Ca 2ϩ release from intracellular pools and influx of extracellular Ca 2ϩ . In confirmation of this, we found a close correlation between pepsinogen release and [Ca 2ϩ ] i in response to SL-NH 2 (Fig. 4C) .
Secretion induced by SL-NH2 is modulated by Ca
2ϩ -mediated agonists. Because these data indicate that SL-NH 2 causes Ca 2ϩ mobilization, we then investigated whether agents that stimulate pepsinogen release through a Ca 2ϩ -dependent or -independent mechanism modulates the chief cells' response to PAR-2 activation. As shown in Table 1 , we found that, although SL-NH 2 -stimulated secretion was additive to that induced by maximally effective concentrations of secretin, VIP, and PGE 2 (12-16, 31, 32, 34, 35) , secretion induced by maximally effective concentrations (12-16, 31, 32, 34, 35) of phospholipase C (PLC)-Ca 2ϩ -activating agents (carbachol, CCK-8, and thapsigargin) remained unchanged. Thus pepsinogen secretion induced by SL-NH 2 is additive to secretion caused by agents that activate a cAMP-PKA pathway. To further investigate whether potentiation observed with maximally effective concentrations of agonists shown in Table 1 was maintained when submaximally effective concentrations of these agonists were used, chief cells incubated with increasing concentrations of PGE 2 were challenged with 1 nM SL-NH 2 . As shown in Fig. 5A , in this setting, SL-NH 2 still potentiates pepsinogen release induced by PGE 2 . The reverse was also true, because the maximally effective concentration of PGE 2 (1 M) potentiates pepsinogen release induced by submaximally effective concentrations of SL-NH 2 (Fig.  5C ). As illustrated in Fig. 5B , the rate of pepsinogen secretion induced by 1 nM SL-NH 2 and 1 M PGE 2 was statistically different from that induced by each agent alone, resulting in a pepsinogen releasing rate of 1.5 Ϯ 0.1% per minute in the first 15-min period (P Ͻ 0.01 vs. cells incubated with SL-NH 2 or PGE 2 alone, n ϭ 5). In contrast, coincubating chief cells with submaximally effective concentrations of carbachol did not affect pepsinogen release induced by a maximally effective concentration of SL-NH 2 (Fig. 5, D and E) , nor did carbachol-potentiated secretion induced by submaximally effective concentrations of SL-NH 2 (Fig. 5F ). Furthermore, pepsinogen secretion induced by SL-NH 2 was not affected by the addition of 100 M atropine to the incubation medium; pepsinogen release was 18.3 Ϯ 2.5% in cells incubated with 1 nM SL-NH 2 alone and 17.8 Ϯ 2.8% in cells incubated with SL-NH 2 plus atropine (n ϭ 4, P Ͼ 0.05). Similarly, secretion induced by SL-NH 2 was not affected by incubating chief cells with indomethacin. Thus basal secretion of 1.4 Ϯ 0.4 rose to 17.5 Ϯ 3.1% in response to SL-NH 2 (1 nM) and to 18.3 Ϯ 2.4% in cells incubated with SL-NH 2 plus indomethacin (100 M) (P Ͼ 0.05 compared with SL-NH 2 alone). In cells incubated with indomethacin alone, secretion was 4.2 Ϯ 1.2 (P Ͻ 0.05 vs. control, n ϭ 4).
SL-NH 2 desensitizes pepsinogen secretion induced by
Ca 2ϩ -mediated agonists. As illustrated in Table 2 and Fig. 6 , A and B, chief cells pretreated with SL-NH 2 and trypsin (1 nM) not only released significantly less pepsinogen in response to a second stimulation with the mimetic peptide, but also pepsinogen secretion induced by trypsin, carbachol, CCK-8, and thapsigargin was markedly curtailed (Table 2 ). In contrast, preexposure to SL-NH 2 (1 nM) had no effect on secretion stimulated by secretin, VIP, and PGE 2 ( Table 2) .
SL-NH 2 causes ERK1/2 phosphorylation. Exposure of gastric-isolated chief cells to SL-NH 2 caused ERK phosphorylation (Fig. 7A) . Both 42-and 44-kDa ERK were activated after 5 min of incubation with 10 nM SL-NH 2 and are maximally activated within 15 min. ERK activation by SL-NH 2 is concentration dependent (Fig. 7B) . These data were confirmed when ERK1/2 activity was assayed. As illustrated in Fig. 7C , exposure to SL-NH 2 but not to LS-NH 2 caused a concentration-dependent increase in ERK activity (P Ͻ 0.01 vs. control, n ϭ 5). Because these data implied that tyrosine kinases are involved in modulating ERK activation in response to SL-NH 2 , we then assessed whether tyrosine kinase and ERK inhibitors modulate pepsinogen release in response to PAR-2 activation. As shown in Table 3 , exposure to genistein, tyrophostin 51, staurosporine, and PD-98,059, a selective MEK inhibitor (1), caused a 40-60% inhibition of pepsinogen release induced by SL-NH 2 (P Ͻ 0.01 vs. SL-NH 2 alone, n ϭ 6). As shown in Table 3 , inhibition of pepsinogen secretion induced by genistein, tyrophostin 51, staurosporine, and PD-98,059 associates with inhibition of ERK phosphorylation.
Pepsinogen release induced by SL-NH 2 is substance P independent. Because previous studies (17, 19-21, 33, 36) have demonstrated that in vivo administration of SL-NH 2 stimulates substance P and CGRP release from enteric neurons, we then investigated whether these two neuropetides modulate secretory response to SL-NH 2 in vitro. As illustrated in Fig. 8 , although CGRP failed to stimulate pepsinogen secretion, exposure to 1 M substance P caused a fourfold increase in pepsinogen release (P Ͻ 0.01 vs. medium, n ϭ 6). Consistent with previous reports (15, 22) , this effect was reversed by coincubating the cells with a neurokinin (NK) 1 , but not NK 2 , antagonist. Indeed, although exposure to 10 M L-732,138, a selective NK 1 antagonist, abolished the stimulation caused by substance P (P Ͻ 0.05, n ϭ 6), exposure to MEN-10,376, a highly selective NK 2 antagonist, failed to reduce pepsinogen secretion induced by substance P (P Ͼ 0.05, n ϭ 6). Interestingly, both compounds failed to affect pepsinogen secretion induced by SL-NH 2 . In addition, as shown in Fig. 8B , capsaicin pretreatment had no effect on chief cells' response to 1 nM SL-NH 2 (P Ͼ 0.05 capsaicin-pretreatment vs. naive, n ϭ 4).
DISCUSSION
In the present study, we have provided evidence that isolated gastric chief cells express receptor for PAR-2 and that PAR-2 activation with short mimetic peptide potently stimulates pepsinogen secretion by activating a number of intracellular messengers including protein-tyrosine kinases, ERK1/2, and Ca 2ϩ. In other cell models, PAR-2 couples G␣ q/11 and phospholipase C␤, leading to hydrolysis of phosphatidylinositol bisphosphate, Ca 2ϩ mobilization, and activation of PKC and ERK1/2 (8, 9, 26) . Here we demonstrated that exposure of gastric chief cells to SL-NH 2 causes Ca 2ϩ mobilization but that Ca 2ϩ is required to release pepsinogen. Indeed, incubating the cells with BAPTA, an agent that binds intracellular Ca 2ϩ , in a Ca 2ϩ -free medium abolishes pepsinogen secretion stimulated by SL-NH 2 (12) (13) (14) . Consistent with the view that pepsinogen release induced by PAR-2 activation is due to a Ca 2ϩ -mediated mechanism is the observation that pepsinogen release induced by SL-NH 2 was additive with secretion stimulated by PGE 2 , secretin, and VIP (i.e., agents that stimulate pepsinogen release by cAMP/ PKA-dependent pathway) but not with pepsinogen release induced by carbachol, gastrin, and thapsigargin, i.e., agents that cause pepsinogen release through a Ca 2ϩ -mediated pathway (12-16, 31, 32, 34, 35) . Although these results do not allow us to determine whether SL-NH 2 and cAMP-PKA activating agents act on different intracellular pools of pepsinogen, they prove that the ability of chief cells to respond to PAR-2 is largely dependent on the presence of other agonists/ antagonists at the chief cell surface. Confirming the complexity of these interactions, we have also documented that SL-NH 2 could desensitize pepsinogen secretion induced by carbachol and CCK-8 but not secretion induced by secretin, VIP, and PGE 2 (12) (13) (14) (15) (16) 31) .
DeFea et al. (8) have previously demonstrated that PAR-2 activates ERK1/2 through a PKC-dependent, pertussis toxin-insensitive pathway by a mechanism that requires receptor association into a multiprotein complex comprising internalized PAR-2 receptor, ␤-arrestin, raf-1, activated ERK1/2, and perhaps other components of the MAPK pathway (8, 9, 24, 26) . Here we demonstrated that exposure of gastric chief cells to SL-NH 2 increases ERK1/2 activity and that tyrosine kinase inhibitors, genestein, staurosporine, and tyrophostin 5 inhibit ERK1/2 phosphorylation induced by SL-NH 2 and cause a 50-60% inhibition of pepsinogen release (14) . Confirming the role of ERK1/2 in regulating pepsinogen release induced by SL-NH 2 , exposure to PD-98,059, a selective MEK inhibitor (1), significantly reduced pepsinogen release induced by SL-NH 2 . However, the finding that the amount of pepsinogen secretion inhibited by PD-98,059 and tyrosine kinase inhibitors is lower than that inhibited by BAPTA suggests that ERK1/2 function to increase the amplitude of the secretory response rather than to provide an obligate signal for this response to occur (14) .
Desensitization is the decrease of a biological response to repeated exposure to an agonist or to continued presence of an agonist (12) (13) (14) (15) (16) . In the present study, we demonstrated that preexposure to SL-NH 2 results in a rapid desensitization of pepsinogen secretion induced by subsequent stimulation with SL-NH 2 , trypsin, and other Ca 2ϩ -mediated agonists (12-16, 31, 32, 34, 35) . Trypsin, the putative endogenous ligand for PAR-2, could desensitize pepsinogen secretion induced by SL-NH 2 by at least three different mechanisms (3, 9, 26) : 1) enzymatic cleavage of the receptor, which ensures that a single receptor molecule, once cleaved, cannot be reactivated by trypsin; 2) receptor phosphorylation and uncoupling from G proteins; and 3) inhibition of more distal steps of intracellular signaling ma- Fig. 8 . Effect of selective NK1 and NK2 antagonists on pepsinogen secretion induced by SL-NH2, substance P (SP), and calcitonin generelated peptide (CGRP). A: isolated gastric chief cells were prepared as described in MATERIALS AND METHODS and were incubated for 30 min with 1 nM SL-NH2, 1 M SP, and 1 M CGRP alone or in the presence of 10 M L-732,138 and MEN-10,376. Results are means Ϯ SE from 6 experiments. *P Ͻ 0.01 vs. medium; **P Ͻ 0.01 vs. SL-NH2 alone. B: ablation of extrinsic afferent neurons of gastrointestinal tract in vivo by capsaicin has no effect on chief cell sensitivity to SL-NH2. Guinea pigs were pretreated in vivo with capsaicin, and chief cells were prepared from naïve or neuron-ablated animals. Results are means Ϯ SE from 4 experiments. *P Ͻ 0.01 vs. basal. chinery. In contrast, SL-NH 2 activates PAR-2 without receptor cleavage; thus desensitization caused by this peptide could only result from G proteins uncoupling and/or inhibition of downstream signals. The finding that preexposure to SL-NH 2 desensitizes pepsinogen secretion induced by carbachol and CCK-8 indicates that the main mechanism of pepsinogen secretion desensitization caused by this peptide lies downstream to the receptor (12) (13) (14) (15) (16) 31 ). This hypothesis is further supported by data obtained with thapsigargin. Indeed, exposure of gastric-isolated chief cells to thapsigargin inhibits a Ca 2ϩ -ATPase that is responsible for the reuptake of cytosolic Ca 2ϩ by intracellular stores, resulting in sustained increase of [Ca 2ϩ ] i and pepsinogen release (14) . Thus the finding that SL-NH 2 desensitizes pepsinogen secretion induced by thapsigargin is further evidence that PAR-2 activation stimulates a Ca 2ϩ -dependent pathway and that Ca 2ϩ mobilization is strictly required for pepsinogen release induced by SL-NH 2 .
Although PAR-2 has been characterized as a trypsinsensitive receptor (1-4, 9, 26) , the potential for trypsin itself to be the preferred endogenous activator of PAR-2 in all tissues remains controversial. The high level of expression of PAR-2 in the small intestine and colon suggest the potential for direct activation of PAR-2 to occur by trypsin released from its zymogen precursor, the trypsinogen, by enteric peptidases within the intestinal lumen (1, 20, 21, 25, (27) (28) (29) (30) . In other parts of the gastrointestinal tract, including the stomach, however, it is unlikely that sufficient trypsin is generated in the lumen to directly activate PAR-2. However, trypsinogen concentrations in the blood increase physiologically after a meal, making possible blood-derived trypsin activation of gastric PAR-2, establishing an integratory feedback loop that might contribute to modulate pepsinogen release in response to food (26) . Indeed, pancreatic trypsin is secreted in an episodic manner, with high levels after feeding and lower levels between meals. The finding that exposure to PAR-2 desensitizes pepsinogen secretion by a combination of effects on several components of the signaling pathway suggests that this period of cell refractoriness could be used by chief cells to replenish surface PAR-2 by mobilizing intracellular pools and/or by synthesis of new receptors.
One persistent ambiguity regarding the physiological role of PAR-2 derives from the observation that PAR-2 receptors are found on 50 -60% of enteric neurons and that activation of PAR-2 by endogenous ligands or synthetic peptides stimulates capsaicin-sensitive sensory neurons to release CGRP and substance P, an endogenous NK 1 -preferential agonist with some NK 2 activity (7, 9, 11, 26, 33, 36) . Treating rodents with capsaicin to ablate extrinsic afferent innervation reduces inflammation induced by SL-NH 2 , demonstrating that CGRP and substance P are responsible, at least in part, for the final physiological effect of PAR-2 (4, 5, 11, 17, 20, 23, 36) . With the use of a purified preparation of gastric chief cells, we have now demonstrated that PAR-2 activation directly stimulates pepsinogen release from gastric-isolated chief cells. We (15) and others (22) have previously demonstrated that gastric chief cells release pepsinogen in response to stimulation with sensory neuropetides. However, a role for these mediators in the effect exerted by PAR-2 is not similar because: 1) CGRP has no direct stimulatory effect on pepsinogen release by gastric chief cells (present study); 2) although substance P stimulates pepsinogen release, this peptide is significantly less effective than SL-NH 2 (present data and Ref. 15); 3) selective NK 1 and NK 2 receptor antagonist did not alter pepsinogen release induced by SL-NH 2 (15, 22) ; and 4) in vivo exposure to capsaicin fails to affect the response of gastric chief cells to SL-NH 2 . Together with the finding that PAR-2 is expressed on gastric chief cells and that PAR-2 activation in vivo and/or in vitro stimulates salivary (19) , gastric (23) , pancreatic (25, 28) , and intestinal (37) secretion, our data establish a common regulatory function for this receptor through the gastrointestinal tract.
In conclusion, our results demonstrate that gastricisolated, pepsinogen-secreting chief cells express a receptor for PAR-2 and that PAR-2 activation potently stimulates pepsinogen by activating a number of intracellular messengers, including protein-tyrosine kinase ERK1/2, and by causing Ca 2ϩ mobilization. Together with previous findings demonstrating that PAR-2 activates salivary and pancreatic secretion, our data support the hypothesis that PAR-2 is a regulatory receptor for gastrointestinal exocrine glands.
